The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $9.37

Today's change0.00 0.00%
Updated August 22 3:39 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $9.37

Today's change0.00 0.00%
Updated August 22 3:39 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc unchanged

Spectrum Pharmaceuticals Inc is unchanged today sitting at (U.S.)$9.37. Over the last five days, shares are unchanged, but are currently 3.40% below its 52-week high. This security has outperformed the S&P 500 by 43.04% during the last year.

Key company metrics

  • Open(U.S.) $9.41
  • Previous close(U.S.) $9.37
  • High(U.S.) $9.45
  • Low(U.S.) $9.27
  • Bid / Ask(U.S.) $9.37 / (U.S.) $9.38
  • YTD % change+111.51%
  • Volume392,458
  • Average volume (10-day)1,120,201
  • Average volume (1-month)1,007,687
  • Average volume (3-month)829,213
  • 52-week range(U.S.) $3.21 to (U.S.) $9.70
  • Beta1.34
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.99
Updated August 22 3:39 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.30%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue34293533
Total other revenue--------
Total revenue34293533
Gross profit21192424
Total cost of revenue13101110
Total operating expense53505349
Selling / general / administrative17191819
Research & development15151613
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-18-21-17-16
Interest income (expense), net non-operating-2-2----
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-23-19-18
Income after tax-20-23-17-17
Income tax, total00-20
Net income-20-23-17-17
Total adjustments to net income--------
Net income before extra. items-20-23-17-17
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-23-17-17
Inc. avail. to common incl. extra. items-20-23-17-17
Diluted net income-20-23-17-17
Dilution adjustment--------
Diluted weighted average shares79798079
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.29-0.22-0.22
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.26-0.29-0.22-0.22